1.
Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE). J of Skin. 2017;1(3.1):s37. doi:10.25251/skin.1.supp.36